Blocking DNA production in cancer therapy by targeting the POLtheta enzyme

Digital transformation conceptual for next generation technology era

BRCA1 (BReast CAncer Gene 1), a key gene that becomes faulty in some instances, leading to breast and ovarian cancer, plays an important role in the body’s DNA repair mechanisms. BRCA1, once mutated, can cause cancer to develop. According to the Center for Familial Breast and Ovarian Cancer at the Vienna General Hospital, it is believed that if the BRCA1 or BRCA2 gene is mutated, the likelihood of developing breast and ovarian cancer increases to 85% and 53% respectively.

These early Black Friday sex toy deals will have you buzzing with excitement

Previous article

Alcohol misuse is an overlooked risk factor for severe COVID-19, according to a review of evidence

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations